AR051517A1 - Aislamiento y purificacion de proteinas - Google Patents
Aislamiento y purificacion de proteinasInfo
- Publication number
- AR051517A1 AR051517A1 ARP050104994A ARP050104994A AR051517A1 AR 051517 A1 AR051517 A1 AR 051517A1 AR P050104994 A ARP050104994 A AR P050104994A AR P050104994 A ARP050104994 A AR P050104994A AR 051517 A1 AR051517 A1 AR 051517A1
- Authority
- AR
- Argentina
- Prior art keywords
- escpr
- region
- concentration
- fusion protein
- purifying
- Prior art date
Links
- 238000009413 insulation Methods 0.000 title 1
- 102000004169 proteins and genes Human genes 0.000 title 1
- 108090000623 proteins and genes Proteins 0.000 title 1
- 238000000746 purification Methods 0.000 title 1
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 abstract 2
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 abstract 2
- 102000037865 fusion proteins Human genes 0.000 abstract 2
- 108020001507 fusion proteins Proteins 0.000 abstract 2
- 230000000712 assembly Effects 0.000 abstract 1
- 238000000429 assembly Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/61—Growth hormone [GH], i.e. somatotropin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
- C07K14/425—Zeins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/485—Epidermal growth factor [EGF], i.e. urogastrone
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/585—Calcitonins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K19/00—Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/14—Fungi; Culture media therefor
- C12N1/16—Yeasts; Culture media therefor
- C12N1/18—Baker's yeast; Brewer's yeast
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8216—Methods for controlling, regulating or enhancing expression of transgenes in plant cells
- C12N15/8221—Transit peptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
- C12N15/8257—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/04—Fusion polypeptide containing a localisation/targetting motif containing an ER retention signal such as a C-terminal HDEL motif
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
- C07K2319/735—Fusion polypeptide containing domain for protein-protein interaction containing a domain for self-assembly, e.g. a viral coat protein (includes phage display)
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Medicinal Chemistry (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Gastroenterology & Hepatology (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Microbiology (AREA)
- Endocrinology (AREA)
- Toxicology (AREA)
- Physics & Mathematics (AREA)
- Botany (AREA)
- Plant Pathology (AREA)
- Cell Biology (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Crystallography & Structural Chemistry (AREA)
- Analytical Chemistry (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Se describe un procedimiento para purificar una proteína de fusion recombinante que se expresa como ensamblajes similares a cuerpos proteicos recombinantes (ESCPR) en células hospedadoras, en el que se proporciona un homogeneizado acuoso de las células hospedadoras transformada que expresan una proteína de fusion como ESCPR con una densidad predeterminada. En el homogeneizada se forman regiones de diferente densidad, proporcionando una region que contiene una concentracion relativamente enriquecida en ESCPR y una region que contiene una concentracion relativamente baja de ESCPR. La region baja de ESCPR se separa a partir de la region de concentracion relativamente enriquecida en ESCPR, purificando así dicha proteína de fusion. A continuacion, la region de concentracion relativamente enriquecida en ESCPR se recoge segun se desee.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0426161.6A GB0426161D0 (en) | 2004-11-29 | 2004-11-29 | Protein isolation and purification |
Publications (1)
Publication Number | Publication Date |
---|---|
AR051517A1 true AR051517A1 (es) | 2007-01-17 |
Family
ID=33561507
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP050104994A AR051517A1 (es) | 2004-11-29 | 2005-11-29 | Aislamiento y purificacion de proteinas |
Country Status (12)
Country | Link |
---|---|
US (1) | US20060123509A1 (es) |
EP (1) | EP1819820A1 (es) |
JP (1) | JP2008521767A (es) |
KR (1) | KR20070091157A (es) |
CN (1) | CN101103114B (es) |
AR (1) | AR051517A1 (es) |
AU (1) | AU2005308922B2 (es) |
BR (1) | BRPI0517120A (es) |
CA (1) | CA2589158A1 (es) |
GB (1) | GB0426161D0 (es) |
RU (1) | RU2420585C2 (es) |
WO (1) | WO2006056484A1 (es) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2224792B1 (es) * | 2002-06-28 | 2007-02-16 | Era Plantech, S.L. | Produccion de peptidos y proteinas por acumulacion de cuerpos proteicos derivados de reticulos endoplasmico en plantas. |
GB0426160D0 (en) * | 2004-11-29 | 2004-12-29 | Era Plantech S L | Production of proteins |
US8163880B2 (en) * | 2006-02-23 | 2012-04-24 | Era Biotech S.A. | Production of biologically active proteins |
JP5667062B2 (ja) | 2008-10-10 | 2015-02-12 | エラ、ビオテック、ソシエダッド、アノニマEra Biotech, S.A. | 免疫原特異的アジュバントとしての組換えタンパク粒 |
DK2552934T3 (en) * | 2010-03-30 | 2015-09-28 | Novozymes As | Krystalmetabolit-extraction |
EP2418284A1 (en) | 2010-08-13 | 2012-02-15 | ERA Biotech, S.A. | Protein body-inducing polypeptide sequences |
EP2468870A1 (en) * | 2010-12-23 | 2012-06-27 | Philip Morris Products S.A. | Method for expressing desxoyribonuclease in plants |
EP2468871A1 (en) * | 2010-12-23 | 2012-06-27 | Philip Morris Products S.A. | Method for producing apolipoprotein in plants |
EP2665817A1 (en) | 2011-01-17 | 2013-11-27 | Philip Morris Products S.a.s. | Vectors for nucleic acid expression in plants |
PT2665818T (pt) | 2011-01-17 | 2017-07-05 | Philip Morris Products Sa | Expressão de proteínas em plantas |
DE102015107846A1 (de) | 2015-05-19 | 2016-11-24 | Johann Wolfgang Goethe-Universität Frankfurt | Synthetische Organellen in Hefe |
CN105285314A (zh) * | 2015-09-14 | 2016-02-03 | 哈尔滨工业大学 | 一种13KDa大米醇溶蛋白的提取方法 |
CN108503686A (zh) * | 2018-05-07 | 2018-09-07 | 江苏省中国科学院植物研究所 | 一种植物总蛋白的提取方法及其专用提取液 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4215040A (en) | 1978-12-22 | 1980-07-29 | The Procter & Gamble Company | Density separation process |
FR2500937B1 (es) | 1981-02-27 | 1983-04-15 | Thomson Csf | |
US5948682A (en) * | 1991-02-22 | 1999-09-07 | Sembiosys Genetics Inc. | Preparation of heterologous proteins on oil bodies |
EP1019517B2 (en) | 1997-09-30 | 2014-05-21 | The Regents of The University of California | Production of proteins in plant seeds |
AU2003239895C1 (en) * | 2002-05-24 | 2010-01-07 | Medtronic, Inc. | Methods and DNA constructs for high yield production of polypeptides |
ES2224792B1 (es) * | 2002-06-28 | 2007-02-16 | Era Plantech, S.L. | Produccion de peptidos y proteinas por acumulacion de cuerpos proteicos derivados de reticulos endoplasmico en plantas. |
GB0426160D0 (en) * | 2004-11-29 | 2004-12-29 | Era Plantech S L | Production of proteins |
US8163880B2 (en) * | 2006-02-23 | 2012-04-24 | Era Biotech S.A. | Production of biologically active proteins |
JP5667062B2 (ja) * | 2008-10-10 | 2015-02-12 | エラ、ビオテック、ソシエダッド、アノニマEra Biotech, S.A. | 免疫原特異的アジュバントとしての組換えタンパク粒 |
EP2418284A1 (en) * | 2010-08-13 | 2012-02-15 | ERA Biotech, S.A. | Protein body-inducing polypeptide sequences |
-
2004
- 2004-11-29 GB GBGB0426161.6A patent/GB0426161D0/en not_active Ceased
-
2005
- 2005-11-29 US US11/289,264 patent/US20060123509A1/en not_active Abandoned
- 2005-11-29 JP JP2007541878A patent/JP2008521767A/ja active Pending
- 2005-11-29 AR ARP050104994A patent/AR051517A1/es not_active Application Discontinuation
- 2005-11-29 WO PCT/EP2005/012878 patent/WO2006056484A1/en active Application Filing
- 2005-11-29 EP EP05816137A patent/EP1819820A1/en not_active Withdrawn
- 2005-11-29 CA CA002589158A patent/CA2589158A1/en not_active Abandoned
- 2005-11-29 KR KR1020077014383A patent/KR20070091157A/ko not_active Application Discontinuation
- 2005-11-29 CN CN2005800470330A patent/CN101103114B/zh not_active Expired - Fee Related
- 2005-11-29 AU AU2005308922A patent/AU2005308922B2/en not_active Ceased
- 2005-11-29 RU RU2007124377/10A patent/RU2420585C2/ru not_active IP Right Cessation
- 2005-11-29 BR BRPI0517120-2A patent/BRPI0517120A/pt not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
GB0426161D0 (en) | 2004-12-29 |
BRPI0517120A (pt) | 2008-09-30 |
RU2420585C2 (ru) | 2011-06-10 |
EP1819820A1 (en) | 2007-08-22 |
RU2007124377A (ru) | 2009-01-10 |
WO2006056484A1 (en) | 2006-06-01 |
AU2005308922B2 (en) | 2011-07-28 |
AU2005308922A1 (en) | 2006-06-01 |
CN101103114B (zh) | 2013-01-02 |
CN101103114A (zh) | 2008-01-09 |
KR20070091157A (ko) | 2007-09-07 |
JP2008521767A (ja) | 2008-06-26 |
US20060123509A1 (en) | 2006-06-08 |
CA2589158A1 (en) | 2006-06-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR051517A1 (es) | Aislamiento y purificacion de proteinas | |
AR062069A1 (es) | Replegado de proteinas recombinantes | |
CL2007001335A1 (es) | Anticuerpo anti cd40; acido nucleico que lo codifica; celula; cultivo celular; metodo de produccion; composicion farmaceutica; metodo para seleccionar un anticuerpo anti cd40; y su uso para tratar sintomas de un trastorno autoinmune y/o un trastorno inflamatorio y/o para reducir el rechazo al injerto y/o para el tratamiento de cancer positivos a cd40. | |
PE20150645A1 (es) | Proteinas de fusion de interleuquina 10 y usos de las mismas | |
EA200901520A1 (ru) | Способ производства очищенного природного газа из природного газа, содержащего воду и диоксид углерода | |
ATE491722T1 (de) | Herstellung und reinigung von il-29 | |
BR112012014736A2 (pt) | purificação de isopreno a partir de recursos renováveis | |
PH12020500027A1 (en) | Purification of iduronate-2-sulfatase | |
EA201200861A1 (ru) | Антагонисты pcsk9 | |
ITTO20040410A1 (it) | Procedimento per la fabbricazione di travi strutturali in composito per aeromobili. | |
HN2008001104A (es) | Compuestos para anticuerpos de dickpf-1 y70-4 | |
BR112014002546A2 (pt) | "colágeno 7, ou seu fragmento funcional, seus métodos de produção e de purificação, sua preparação purificada ou isolada, vetor, coleção de vetores, preparação isolada de células, cultura celular, e método para produção de uma célula adequada à expressão de colágeno 7" | |
PE20170906A1 (es) | Alfa-glucosidasa acida muy potente con hidratos de carbono potenciados | |
PE20131072A1 (es) | Metodo para recuperar oro por extraccion con solvente | |
PA8813901A1 (es) | Paramixovirus oncolíticos atenuados que codifican citoquinas de aves | |
AR089362A1 (es) | Metodos para mejorar las etapas de purificacion de proteinas descendentes utilizando cromatografia de membranas de intercambio ionico | |
BR112012024550A2 (pt) | processo para purificação de proteínas dependentes de vitamina k tal como o fator de coagulação ix | |
AR053287A1 (es) | Metodos para mejorar la arquitectura y el rendimiento de plantas de cultivo | |
AR104358A1 (es) | Método para la purificación de proteínas | |
AR085275A1 (es) | Conversion de sulfuro de hidrogeno en azufre usando una solucion de yodo regenerada | |
CL2015002664A1 (es) | Método para remover un contaminante de una composición biológica que contiene contaminante útil como materia prima de un biocombustible | |
CL2007003859A1 (es) | Metodo para eliminar arsenico que comprende contactar la solucion con un agente precipitante de tierra rara para precipitar arsenico y obtener solucion parcialmente liberada de arsenico y agente cargado con arsenico,contactar la solucion separada con una segunda porcion de agente precipitante;y aparato para separar arsenico. | |
EA200701703A1 (ru) | Извлечение серной кислоты | |
WO2011059189A3 (ko) | 항-tm4sf1 항체를 이용한 중간엽줄기세포 동정방법 및 그 조성물 | |
IT1396528B1 (it) | Nuovo processo di purificazione altamente selettivo di due proteine plasmatiche: von willebrand factor (vwf) e fibronectina (fn). |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure | ||
FC | Refusal |